COMMONWEALTH EQUITY SERVICES, LLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 312272 WALTHAM, MA

Position in TSHA

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$261,235

-$44,878 QoQ

Shares Held

58,442

+5.0% QoQ

Ownership

0.020%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Healthcare · as of Mar 31, 2026

COMMONWEALTH EQUITY SERVICES, LLC holds $113,564,491 across 120 Biotechnology names. TSHA ranks #55 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	54,972	$24,547,196
2	REGN	Regeneron Pharmaceuticals, Inc.	16,385	$12,659,706
3	EXEL	Exelixis, Inc.	173,762	$7,452,652
4	TGTX	Tg Therapeutics, Inc.	180,285	$5,989,067
5	TARS	Tarsus Pharmaceuticals, Inc.	80,892	$5,674,573
6	CRSP	CRISPR Therapeutics AG	78,488	$3,733,674
7	ALNY	Alnylam Pharmaceuticals, Inc.	10,577	$3,499,611
8	ARWR	Arrowhead Pharmaceuticals, Inc.	55,076	$3,453,265

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$261,235	58,442	+5.0%	Shares	Sole	2026-04-27
2025-12-31	$306,113	55,657	-4.5%	Shares	Sole	2026-02-12
2025-09-30	$190,500	58,257	-3.0%	Shares	Sole	2025-10-22
2025-06-30	$138,683	60,036	-0.1%	Shares	Sole	2025-08-06
2025-03-31	$83,495	60,069	+1.7%	Shares	Sole	2025-05-09
2024-12-31	$102,189	59,069	+110.4%	Shares	Sole	2025-02-10
2024-09-30	$56,418	28,069	+2.9%	Shares	Sole	2024-10-18
2024-06-30	$61,082	27,269	0.0%	Shares	Sole	2024-07-31
2024-03-31	$78,262	27,269	+1.9%	Shares	Sole	2024-04-29
2023-12-31	$47,381	26,769	-0.7%	Shares	Sole	2024-02-06
2023-09-30	$85,228	26,971	+44.0%	Shares	Sole	2023-10-23
2023-06-30	$12,377	18,725	0.0%	Shares	Sole	2023-08-10
2023-03-31	$14,942	18,725	+36.4%	Shares	Sole	2023-05-11
2022-12-31	$31,018	13,725	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.